Article
Hemophilia gene therapy comes of age
8 Dec 2017
Abstract excerpt
genes over 3 decades ago allowed for the development of recombinant factor products and made the hemophilias a target disease for gene transfer. The progress of hemophilia gene therapy has been announced in 3 American Society of Hematology scientific plenary sessions, including the first "cure" in a large animal model of hemophilia B in 1998, first in human sustained vector-derived factor IX activity in 2011, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
